ATE209493T1 - Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression - Google Patents

Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression

Info

Publication number
ATE209493T1
ATE209493T1 AT97921706T AT97921706T ATE209493T1 AT E209493 T1 ATE209493 T1 AT E209493T1 AT 97921706 T AT97921706 T AT 97921706T AT 97921706 T AT97921706 T AT 97921706T AT E209493 T1 ATE209493 T1 AT E209493T1
Authority
AT
Austria
Prior art keywords
pct
aspirochlorine
immunosupression
derivatives
sec
Prior art date
Application number
AT97921706T
Other languages
English (en)
Inventor
Khalid Islam
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE209493T1 publication Critical patent/ATE209493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97921706T 1996-05-03 1997-04-23 Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression ATE209493T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96106991 1996-05-03
PCT/EP1997/002049 WO1997041862A1 (en) 1996-05-03 1997-04-23 Use of aspirochlorine or derivatives thereof as immunosuppressive agents

Publications (1)

Publication Number Publication Date
ATE209493T1 true ATE209493T1 (de) 2001-12-15

Family

ID=8222742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97921706T ATE209493T1 (de) 1996-05-03 1997-04-23 Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression

Country Status (13)

Country Link
US (1) US6133254A (de)
EP (1) EP0914129B1 (de)
JP (1) JP4287908B2 (de)
KR (1) KR100439928B1 (de)
AT (1) ATE209493T1 (de)
AU (1) AU705290B2 (de)
CA (1) CA2253635C (de)
DE (1) DE69708645T2 (de)
DK (1) DK0914129T3 (de)
ES (1) ES2163763T3 (de)
IL (1) IL126548A (de)
PT (1) PT914129E (de)
WO (1) WO1997041862A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007287928A (ja) 2006-04-17 2007-11-01 Nec Electronics Corp 半導体集積回路およびその製造方法ならびにマスク

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001086A (en) * 1975-07-18 1977-01-04 Eli Lilly And Company Antibiotic a-30641 and process for production thereof
US3991052A (en) * 1975-07-18 1976-11-09 Eli Lilly And Company Antibiotic A-30641
JP3383718B2 (ja) * 1995-02-15 2003-03-04 ニチモウ株式会社 大豆蛋白を原料とした生成物の製造方法

Also Published As

Publication number Publication date
IL126548A (en) 2002-02-10
KR20000010724A (ko) 2000-02-25
DE69708645T2 (de) 2002-08-08
JP4287908B2 (ja) 2009-07-01
AU705290B2 (en) 1999-05-20
AU2768497A (en) 1997-11-26
EP0914129B1 (de) 2001-11-28
KR100439928B1 (ko) 2004-12-16
WO1997041862A1 (en) 1997-11-13
CA2253635C (en) 2006-01-03
JP2000514403A (ja) 2000-10-31
EP0914129A1 (de) 1999-05-12
DE69708645D1 (de) 2002-01-10
ES2163763T3 (es) 2002-02-01
IL126548A0 (en) 1999-08-17
DK0914129T3 (da) 2002-01-28
US6133254A (en) 2000-10-17
PT914129E (pt) 2002-04-29
CA2253635A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
DE69621831D1 (de) Piperazinderivative als tachykinin antagonisten
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
AU6613896A (en) Chemical compounds
IL113141A0 (en) Intermediates for hypoglycemic hydroxyurea detivatives
AU7495096A (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
IL129054A0 (en) Benzonaphthyridines as bronchial therapeutics
DK0699207T3 (da) Mellemprodukt til azithromycin
AU5648496A (en) Pyrazolo-(1,5a)pyrimidines, their preparation and their use
AU5320698A (en) Substituted dihydrobenzofurans as pde inhibitors
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DE59808710D1 (de) Verfahren zur herstellung von 2-(3-pyrazolyl-oxymethylen)nitrobenzolen
DE69633943D1 (de) Morphine derivate mit analgetischen eigenschaften
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
IT1285777B1 (it) Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
AP2001002045A0 (en) FKBP inhibitors.
ATE209493T1 (de) Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression
MX207081B (de)
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
GB9607119D0 (en) Compounds
ES2154457T3 (es) Derivados de ciclohexadieno sustituidos con dimetilo.
UA70975C2 (uk) Похідні 1,4-діарил-2-фтор-1-бутен-3-олу, спосіб їх одержання та способи одержання похідних 1,4-діарил-2-фтор-1,3-бутадієну і 1,4-діарил-2-фтор-2-бутену
TW349092B (en) Substituted indole derivatives
UY24326A1 (es) Nuevas piperidinas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification